Human cd33 antibodies and glucocorticoid conjugates
AssigneeEli Lilly and Company
InventorsForest Hoyt Andrews, Joshua Ryan Clayton, Ross Edward Fellows, Bo Ma, Ying Tang, Jacqueline Mary Wurst, Pia Pauliina Yachi, Chiao-Wen Yang
Life of this patent
Estimating the term…
Abstract
The present disclosure provides human CD33 antibodies and antibody glucocorticoid receptor agonist conjugates and methods of using the conjugates for the treatment of myeloid cell associated diseases.
Claims50
An antibody that binds human CD33, wherein the antibody comprises a heavy chain variable region (VH) and a light chain variable region (VL), wherein the VH comprises heavy chain complementarity determining regions HCDR1, HCDR2, and HCDR3, and the VL comprises light chain complementarity determining regions LCDR1, LCDR2, and LCDR3, wherein:
- i. the HCDR1 comprises SEQ ID NO:
- 1,
- the HCDR2 comprises SEQ ID NO:
- 2,
- the HCDR3 comprises SEQ ID NO:
- 3,
- the LCDR1 comprises SEQ ID NO:
- 4,
- the LCDR2 comprises SEQ ID NO:
- 5, and
- the LCDR3 comprises SEQ ID NO:
- 6;
- ii. the HCDR1 comprises SEQ ID NO:
- 1,
- the HCDR2 comprises SEQ ID NO:
- 2,
- the HCDR3 comprises SEQ ID NO:
- 3,
- the LCDR1 comprises SEQ ID NO:
- 13,
- the LCDR2 comprises SEQ ID NO:
- 5, and
- the LCDR3 comprises SEQ ID NO:
- 6;
- or
- iii. the HCDR1 comprises SEQ ID NO:
- 1,
- the HCDR2 comprises SEQ ID NO:
- 2,
- the HCDR3 comprises SEQ ID NO:
- 17,
- the LCDR1 comprises SEQ ID NO:
- 18,
- the LCDR2 comprises SEQ ID NO:
- 5, and
- the LCDR3 comprises SEQ ID NO:
- 6.
A nucleic acid comprising a sequence encoding SEQ ID NO:
- 9, 10, 15, 21, or 22.
A composition comprising:
- i. a first vector comprising a nucleic acid sequence encoding SEQ ID NO:
- 21 and a second vector comprising a nucleic acid sequence encoding SEQ ID NO:
- 22;
- ii. first vector comprising a nucleic acid sequence encoding SEQ ID NO:
- 9 and a second vector comprising a nucleic acid sequence encoding SEQ ID NO:
- 10;
- or
- iii. a first vector comprising a nucleic acid sequence encoding SEQ ID NO:
- 9 and a second vector comprising a nucleic acid sequence encoding SEQ ID NO:
- 15.
A conjugate of the Formula:
- wherein Ab is an antibody that binds human CD33,
- wherein
- and n is 1-5.
A method of producing a conjugate, comprising the steps of:
- (a) reducing anti-human CD33 antibody with a reducing agent to produce a reduced anti-human CD33 antibody, wherein the anti-human CD33 antibody comprises one or more engineered cysteine residues;
- (b) oxidizing the reduced anti-human CD33 antibody with an oxidizing agent to produce an oxidized anti-human CD33 antibody;
- and
- (c) contacting the oxidized anti-human CD33 antibody with the compound of the formula
- to produce the conjugate.
Dependencies are inferred from the claim text.